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Research collaboration  
at all levels sets us apart
Welcome to the fifth edition of the UNT Health Science Center’s 
(UNTHSC) annual research publication, Synergy. In this issue of Synergy, 
you will see many of our researchers discovering new ways to improve 
the health and well being of Texans.
The cover of Synergy highlights our new virtual reality equipment called 
the CAREN (Computer-Assisted Rehabilitation Environments) system. 
CAREN is a state-of-the-art rehabilitation system that incorporates 
a virtual reality environment with independently controlled treadmills that 
can tilt in any plane, mimicking any number of environments. UNTHSC 
investigators also will use the CAREN system in their research efforts 
to determine how individuals maintain balance on changing terrain. 
This understanding will improve our ability to minimize falls in older 
individuals and others with compromised functional status. Of the five 
CAREN systems in the U.S., UNTHSC is the only academic institution 
operating one.
This is but one example of how UNTHSC researchers, working to 
combat many diseases and disorders, are improving the health of our 
citizens. UNTHSC has committed to expand and lead research efforts in 
a number of areas, such as aging and Alzheimer’s disease, primary care 
and prevention, and investigative genetics.
Last year, we recruited a long-time FBI researcher to head our newly 
formed Institute of Investigative Genetics. We’ve continued to build 
our world-class reputation in this area with the addition of a renowned 
bioinformaticist to head our Center for Computational Epidemiology. 
Combined with our leadership in the Center for Human Identification, 
UNTHSC truly has one of the strongest investigative genetics teams in 
the country.
In the area of primary care and prevention, new faculty recruits have 
solidified UNTHSC as a national leader in community-based participatory 
research. This rapidly developing area of research could reshape 
how we make discoveries in disease prevention, and how we ensure 
implementation of these findings in our communities.
Our researchers have earned an international reputation for combating 
aging at the cellular level, improving diagnostics and treatment for 
Alzheimer’s disease, studying the interaction of exercise and antioxidant 
supplements in affecting cognitive decline, and preventing falls.  
We appreciate your interest in learning more about the important issues 
our investigators are tackling. Whether it be Alzheimer’s disease, heart 
disease, vision loss or diabetes, our scientists are fully dedicated to 
working together to improve lives.
Glenn H. Dillon, Ph.D.
Vice President for Research
glenn.dillon@unthsc.edu
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Welcome to the fifth annual research report for the University of 
North Texas Health Science Center. Research is an integral part of the 
institution’s mission, intimately associated with student training and 
our commitment to the advancement of knowledge. Our scientists lead 
cutting-edge research, analysis and treatment of diseases, and they 
propel our discoveries from the bench to the bedside to the community 
for the betterment of all people.
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Cover Photo: Janice Knebl, Nicoleta Bugnariu and 
Rita Patterson conduct research on the V-Gait CAREN 
system, new virtual reality equipment that addresses 
balance and movement impairments.
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Risks of 
Dennis Thombs’ research into combining alcohol with energy drinks 
sheds new light on drinking in young people.
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For Dennis Thombs, PhD, professor and chair of the Department 
of Social and Behavioral Sciences in the School of Public Health, 
the term “happy hour” has taken on a whole new meaning. For 
more than 20 years, Thombs has studied alcohol use by college 
students — especially so-called college-age binge drinking — leading 
to recent discoveries on the heavily-debated topic of alcoholic energy 
drinks.
Thombs and his research teams have interviewed almost 30,000 
young people leaving bars after a night of partying, generally between 
the hours of 10 p.m. and 3 a.m., recording their drinking practices and 
intent to drive, as well as their breath alcohol concentration levels.
Early in 2010, his first-of-its-kind research evaluated the effects 
of alcohol mixed with energy drinks when consumed in bars. His 
conclusions noted that when caffeine is mixed with alcohol, people may 
perceive that they are less intoxicated than they really are, which may 
lead them to drink more or make inaccurate judgments as to whether 
they can drive safely.
His research indicated that bar patrons who consumed energy drinks 
mixed with alcohol were three times more likely to be highly intoxicated 
than those who drank only alcohol and four times more likely to drive.  
Energy drinkers also drank for longer periods of time and left the bars 
later, which Thombs attributes to the caffeine stimulation that causes a 
“wide-awake” feeling, rather than a sleepy intoxication that other types 
of drinking may produce.
“People are more apt to engage in risky behaviors,” Thombs noted, 
“and they don’t feel as impaired with regard to drinking and driving, even 
though they are.  With as many as 28 percent of college-age drinkers 
mixing alcohol with energy drinks in a typical month, this phenomenon 
quickly has become a critical public health and safety issue, 
because students leave bars and make decisions that are skewed, 
based on how they perceive they are handling the effects of alcohol.”
The Association of Schools of Public Health (ASPH) recently called 
this issue an emerging public health concern. Other studies report 
that students consuming caffeinated alcoholic beverages have double 
the risk of experiencing or committing sexual assault, riding with an 
intoxicated driver, having an alcohol-related accident or requiring 
medical treatment.
The most common alcohol/energy drink combination, Thombs says, 
is Red Bull and vodka. Red Bull is also frequently mixed with cherry 
vodka to create a popular drink called “Cherry Bomb.” With Monster 
being one of the most popular drinks of teenagers, its manufacturer is 
now in competition with Red Bull to enter the bar market, Thombs says. 
Students often begin “pre-drinking” before they go out and then 
continue at bars. They sometimes start with energy drink mixes early 




It is commonly known that exercise and antioxidant intake can improve physical health. But 
could these factors decrease the chances of developing Alzheimer’s disease? 
Nathalie Sumien, PhD, assistant professor of Pharmacology and Neuroscience, recently 
received a two-year grant from the Alzheimer’s Association to examine if a healthy lifestyle 
including exercising and taking antioxidant supplements will protect against declines in 
cognitive function.
In preliminary research, Sumien discovered that combinations of antioxidants such as 
vitamin E and coenzyme Q10, or vitamins E and C, have shown the most promise in reversing 
cognitive decline. Preliminary exercise research at the Health Science Center has shown that a 
moderate level of exercise training, such as easy jogging or swimming, can have a minor impact 
on cognitive function. However, recent studies have suggested a negative interaction of these 
two factors, where antioxidant intake abolished the beneficial effects of exercise.
Sumien’s study will further explore the interactive effects of exercise and antioxidant 
supplementation on cognitive function in females. It will focus on whether exercise and 
consuming antioxidants have more of an impact when done early or later in life. Sumien is 
hopeful results of her study will allow her to determine whether antioxidant intake should be 
recommended for healthy aged and Alzheimer’s patients engaging in moderate exercise. 
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Nathalie Sumien, PhD
Can a healthy lifestyle 
protect against  Alzheimer’s?
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It’s inevitable. Everyone ages. Aging typically 
increases the chance of disease. Dong-Ming Su, 
PhD, associate professor of Molecular Biology and 
Immunology, is researching ways to prevent or 
delay the onset of diseases related to immune 
system aging. 
The National Institutes of Health (NIH) have provided 
more than $2 million in support to Su to investigate 
molecular changes in the thymus, a gland located 
in the front of the neck that regulates the immune 
system. The thymus plays an active role in the 
aging of T cells, white blood cells that attack 
cells infected by bacteria, viruses or other disease-
causing organisms.
T cells are part of the adaptive immune system, 
which is composed of highly specialized, systemic 
cells and processes that eliminate or prevent 
pathogenic challenges. This system is adaptive 
because it can prepare itself for future challenges, 
including infection, tumors or auto-immunity.
“As people get older, it becomes easier for them 
to get infection,” Su said. “Influenza, cancer and 
rheumatoid arthritis are all examples of diseases 
caused from decreasing T cell function.”
The thymus shrinks and fat begins to surround 
it, which prohibits the thymus from producing 
enough new T cells and fighting disease.
Cells in the thymus can be divided into 
thymic stromal cells and hematopoietic stem cells. 
Su’s research team found that the stromal cells 
age more rapidly than the stem cells, which 
challenges traditional thinking. 
“There is a need to change the condition 
of the stromal cells to provide a young 
microenvironment for hematopoietic stem cells,” 
Su said. “We are working to find a way to 
rescue the stromal cells from aging and make the 
microenvironment younger. If the stromal cells do 
not age as quickly, the thymus will not shrink as 
quickly and would be able to produce new T cells.”
Su said this could be accomplished through 
gene regulation, known as gene therapy, or through 
a stem-cell based therapy. While still in the early 
stages of lab research, Su said that gene expression 
could be stimulated through a simple injection.
“Although we are in the early stages of this 
research, this could ultimately change lives,” Su 
said. “The consequences of this research could 
potentially increase life span and improve quality of 






UNT Health Science Center School of Public 
Health researchers Fernando Wilson, PhD, and 
Jim Stimpson, PhD, published a report in the 
American Journal of Public Health showing that 
texting while driving resulted in an estimated 16,000 
fatalities in the U.S. from 2001 to 2007. The report 
indicates that a growing percentage of 
distracted drivers in fatal crashes are males driving 
alone, and the accidents involve collisions with 
roadside obstructions.
Wilson, assistant professor of Health Management 
and Policy, and Stimpson, assistant professor of 
Social and Behavioral Sciences, analyzed traffic 
fatalities across the U.S. from 1999 to 2008 in what 
is being noted as one of the first efforts to place a 
scientific number on the amount of motor vehicle 
deaths resulting from cell phone use.  
The report used data from the National Highway 
Traffic Safety Administration on motor vehicle deaths in 
each state and Federal Communications Commission 
reports on increasing cell phone ownership and 
texting volume over the targeted years. They noted 
that in 2002, one billion texts were sent every month 
on average, and this number skyrocketed to 110 
billion by 2008. For every one million new cell phone 
subscribers, Wilson and Stimpson estimate a 19 
percent rise in deaths from distracted driving. The 
recent and rapid increases in cell phone usage and 
texting may be responsible for thousands of additional 
road fatalities annually in the US.
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America’s obsession with texting
Fernando Wilson, PhD,  
and Jim Stimpson, PhD
The damage that results when a soldier takes 
a bullet in a limb or when someone is trapped in 
a car wreck often requires that the blood supply 
be cut off by applying a tourniquet to keep the 
victim from bleeding to death. Emergency medical 
responders administer fluids intravenously and 
stop the blood flow long enough to treat or 
repair the wound, then release the tourniquet 
to allow blood flow back into the injured limb to 
replenish necessary oxygen and nutrients.  
One would think that the most damaging part 
of the hemorrhagic injury was over, but negative 
effects occur when the tourniquet is released. 
As blood rushes into the oxygen-deprived tissue, 
reactive oxygen species (ROS) are formed. These 
highly reactive molecules can interfere with 
cellular function and damage   muscles and other 
vital organs of the body, including the heart.  
New research being conducted by DO/PhD 
student Hunaid Gurji may lead to changes in 
treatment for hemorrhagic shock by emergency 
care personnel.  
Gurji’s expertise in electrophysiology and 
cardiac performance has spurred him to continue 
research begun by his mentors Robert Mallet, 
PhD, professor of Integrative Physiology, and 
Albert Yurvati, DO (’86), professor and chair 
of Surgery, on the benefits of administering 
pyruvate to trauma victims as soon as possible.  
Pyruvate is a naturally occurring organic 
acid and supplies energy to living cells. By 
administering pyruvate to trauma victims as they 
are transported from the trauma scene to a 
hospital, the researchers hope that pyruvate’s 
anti-oxidant and anti-inflammatory effects will 
protect the heart and other tissues in the body 
from damage due to ischemia-reperfusion injury. 
In addition, pyruvate can act as an excellent 
metabolic fuel for the body’s cells, supplying 
these cells with enough energy to maintain proper 
metabolism and cellular function. These combined 
effects of pyruvate will help guard cells from 
injury and allow quicker recovery.
New research may prevent
cell damage
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Daniel White and Hunaid Gurji
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Glaucoma has been called the sneak thief of 
sight because many of those who suffer from 
the degenerative disease slowly lose their vision, 
although they feel no pain or discomfort. The 
damage that is slowly occurring to the optic nerve 
is a result of building pressure. However, 
because the loss of vision is gradual, most 
people don’t realize that their eyesight is 
deteriorating.
Although glaucoma’s cause is unknown, the 
disease is treated by reducing the fluid in the 
eye or increasing the drainage needed to reduce 
pressure that slowly damages the optical nerve 
and retina. However, this doesn’t repair damage 
to the optic nerve. Research has shown that small 
protein molecules called endothelins increase 
in glaucoma patients, but it isn’t clear how these 
endothelins either protect or damage the eye.
Raghu Krishnamoorthy, PhD, assistant 
professor of Cell Biology and Anatomy and 
member of the North Texas Eye Research 
Institute at the Health Science Center, is trying 
to determine how endothelins produce 
damage to nerve cells in the eye. He hopes 
to find an endothelin antagonist which would 
prevent the damaging effects of endothelins 
and thereby enhance nerve cell survival. 
“The eye is the window to the brain,” 
Krishnamoorthy said. “It’s a very specialized part of 
the central nervous system, and, once it’s lost, it 
can’t be recovered. The next step would be 
finding a way to regenerate the optic nerve once 
it’s damaged.” 





Raghu Krishnamoorthy, PhD,  and Shaoquing He, PhD
Reopening
the window to the brain
—Raghu Krishnamoorthy
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Thousands of Americans die each year from 
conditions stemming from high blood pressure. 
Although stress, dietary salt intake, tobacco use, 
alcohol consumption and lack of exercise are known 
to trigger high blood pressure, obesity is also an 
independent risk factor.
Ann Schreihofer, PhD, associate professor of 
Integrative Physiology, is studying how the brain 
regulates blood pressure in an obese popula-
tion. Schreihofer’s work focuses on how the brain 
regulates blood pressure under normal conditions to 
better understand how it is altered with high blood 
pressure. The metabolic syndrome that occurs with 
excessive weight gain is one of the hypertensive 
models under investigation in her laboratory.
Hypertension is the primary risk factor for death 
in America because high blood pressure increases 
the chance of developing heart disease, peripheral 
vascular disease and stroke. Obesity, a condition 
that affects one-third of the American population, 
also leads to bigger swings in blood pressure that 
are detrimental to normal cardiovascular function. 
Fat cells release chemicals and hormones that can 
act on the brain, and these are elevated when body 
fat accumulates. Schreihofer hopes her research will 
clarify how signals from fat cells affect the brain.
“When people continually struggle with obesity, 
they begin to feel hopeless,” Schreihofer said. “Fac-
tors contributing to obesity are often misunderstood 
and there is more to it than not working hard enough 
to stay on a diet or exercise. People struggling 
with obesity need more than diet and exercise ad-
vice to deal with their obesity-related health issues. 
Regulating their blood pressure could give them hope 
and increase their chance for a longer, better life.”
Schreihofer and her team are focused on 
studying a genetic model of obesity that stems from 
the mutation of the leptin receptor. Leptin, which is 
released by fat calls, normally acts within the brain 
to limit meal size. Without a functional leptin 
receptor hunger never abates, leaving the subject to 
continuously seek out and consume food. Eating 
more food changes the chemistry of the body and 
the brain. Once someone becomes obese, their brain 
does not react as well to stress, leading to changes 
in blood pressure.
“We are trying to determine causes for the inability 
to regulate blood pressure in the setting of obesity,” 
Schreihofer said. “Once we understand how neurons 
in the brain change in an obese population versus 
their lean counterparts, we can ultimately find ways 
to help people.”
Many medications have been developed for 
hypertension, but often they have negative side 
effects. Schreihofer hopes to understand what 
causes the brain to trigger high blood pressure, 
which may lead to therapies to alleviate obesity- 
induced over-activity in brain cells that regulate 
blood pressure.
Her research is funded by a four-year, $1.3 million 
National Institutes of Health grant. 
“We are mid-way through the project. It is a 
basic science project, but in collaboration with 
others the work we do may be useful for future 
clinical trials to treat the deleterious consequences 
of obesity,” Schreihofer said.
Regulating blood pressure 
in the face of obesity
Ann Schreihofer, PhD
In 2008, more than nine percent of adolescents 
reported using illicit drugs, and studies estimate 
that 50 to 80 percent of these young people also 
have a psychiatric disorder. While innovative 
integrative treatment for both the drug use 
and the psychiatric disorders seems to be the 
answer, practitioners need reliable research 
findings to determine which practices are the 
most effective, particularly for low-income and 
minority adolescents.
Assistant Professor Raquel Qualls-Hampton, 
PhD, at the UNTHSC School of Public Health 
aims to analyze the effectiveness of these 
integrative treatments to determine if they 
influence treatment results. In fact, Qualls-
Hampton received a grant  from theprestigious 
Robert Wood Johnson Foundation (RWJF) to 
conduct her research.  
The results from this 24-month, New 
Connections study should provide practitioners 
with guidance on the most effective integrative 
therapies for affected adolescents. Identification 
of effective integrative therapies is important. 
From clinical, access and policy perspectives, 
Qualls-Hampton believes that integrative 
therapies will be proven effective and become 
accessible, particularly for the vulnerable 
populations in critical need of these services.
New Connections is a national program 
designed to introduce new scholars to RWJF and 
expand the diversity of perspectives that inform 
the foundation’s programming. New Connections 
seeks early- to mid-career scholars who are 
historically underrepresented ethnic or racial 
minorities, first-generation college graduates, 
and individuals from low-income communities. 
“I am extremely proud to be among the 
junior investigators honored with this prestigious 
grant,” says Qualls-Hampton. “This award will 
connect me to a network of experts established 
in research and evaluation related to health and 
health care, while providing me with an opportunity 
to evaluate a program that has far-reaching 
implications for adolescents with comorbid 
substance use and mental health conditions.”
Help for adolescents with
drug, psychiatric issues
Raquel Qualls-Hampton, PhD, 
and Monique Shuler
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Esther Han, fourth-year Texas College of 
Osteopathic Medicine (TCOM) student, is currently 
researching the effectiveness of drug treatments 
on HIV and AIDS patients in Beijing, China. The 
study aims to determine the factors that may be 
associated with virologic failure in groups of HIV/AIDS 
patients on highly active antiretroviral therapy. 
“We definitely had some interesting findings 
including a dramatic difference in virologic failure 
rates between patients in two counties in Henan 
Province that are about 70 kilometers apart,” Han 
said. “We hope to get this study published soon.”
Han is also involved with a project to identify 
factors including risky behaviors, ethnicity, age and 
gender that may be associated with incidences 
of the Hepatitis B and C viruses in intravenous drug 
users in China. 
Han’s research is funded by a year-long Fogarty 
International Clinical Research Scholars fellowship 
through the Fogarty International Center, a division 
of the National Institutes of Health. She is working 
in the Chinese Center for Disease Control and 
Prevention’s Office of Virology and Immunology at 
the National Center for AIDS and STDs in Beijing.
Han said conducting research in the international 
setting and working with a Chinese team has been a 
learning experience.
“My learning curve was certainly steep when I 
arrived in late July,” Han said. “Every day is a day 
of learning—from statistics and research design to 
learning statistical analysis software and learning 
how to delicately handle cultural differences that 
manifest themselves daily.”
This is Han’s second trip to China to research 
HIV and sexually transmitted diseases. Before 
starting medical school at TCOM, she spent a year 
researching HIV and AIDS in rural China as part of 
the U.S. Department of State’s prestigious Fulbright 
Program.
After her fellowship, Han will return to TCOM to 
complete her fourth year. After graduation, she will 
pursue urology and plans to continue her research 
on HIV/AIDS and other viruses and their effects on 
the urogenital system. 
Research on
HIV in China
Esther Han evaluates an HIV patient in China.
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Last year, the UNT Health Science Center added 
another dimension to its world-renowned Center for 
Human Identification when it created the Institute 
for Investigative Genetics. In addition to the Center 
for Human Identification, the new institute includes 
the Center for Biosafety and Biosecurity, and the 
Center for Computational Genomics (CCG), led by 
Ranajit Chakraborty, PhD, professor of Forensic & 
Investigative Genetics, who recently joined the UNT 
Health Science Center from the University of Cincinnati 
College of Medicine. The Institute for Investigative 
Genetics  focuses on education, training, research, 
development and community engagement, which 
touch all missions of the Health Science Center from 
the students to clinical research to public health 
aspects.
The CCG enriches the research at the Health 
Science Center in many ways, as its researchers 
work side by side on statistical genetics, 
bioinformatics and biostatistics for biomedical 
and public health research. By applying 
genomic data in biomedical fields, the center 
provides training, research and services to improve 
the quality of life.
Recently evolved genomic tools can be used to 
understand resistance to drug responses and risks 
of specific environmental and lifestyle insults that 
can be influenced by genetic make-up. Research 
into these genetic effects supports the concept of 
individualized medicine, where a patient is treated 
based on genetic traits, expectations and proven 
reactions. 
For example, radiation treatment estimates 
assume that all patients will respond to treatment the 
same way. However, Chakraborty’s earlier  studies 
show some genetic variants make some people 
more sensitive to radioactive exposures. The BRCA1 
gene variants increase the risk of breast cancer and 
appear to indicate a high sensitivity to radiation. The 
center hopes to study the effects of family history 
and genetic make-up on the sensitivity to x-rays, 
CT scans, and mammography, as well as other 
exposures to radiation.
“Treatment works better if a patient isn’t just a 
statistic,” Chakraborty said, “but is treated as a 
person. That includes their health habits, spirituality, 
religiosity, environment and genetic heredity. Health 
disparities may not be as related to a socio-economic 
group as much as it is to a religious or disciplined 
group.”
As part of his research, he works with 
Roberto Cardarelli, DO (’01), and Bandana 
Chakraborty, DrPH, at the Health Science Center’s 
Primary Care Research Institute to determine 
indicators of chronic health effects beyond genetics. 
For example, do more faithful or religious 
people enjoy better health because of more 
disciplined behavior, which leads to less exposure 
to negative agents? His investigations into health 
disparities pull him into research at the Health 
Science Center’s School of Public Health, as he 
searches for the answers to these questions.
In collaboration with the Osteopathic Research 
Center (ORC) and John Licciardone, DO, executive 
director of the ORC, Chakraborty is involved in 
researching low back pain and the role that genetics 
may play in treatment success. These genetic 
effects are called biomarkers and may be important 
to the effectiveness of many different treatments.
Chakraborty and his team also may find themselves 
analyzing familial DNA within state databases of 
criminal offenders. For example, Luther Franklin 
was identified as the Grim Sleeper murderer as the 
result of a familial relationship determined when 
his son Chris Franklin’s DNA was entered into the 
offender database following a felony weapons 
charge. In Texas, the Twilight Rapist could also 
be identified using a similar method. Chakraborty 
currently is working with the states of Texas and New 
York to establish guidelines for use of familial DNA. 
Kansas and Louisiana are also likely to adopt similar 
guidelines.
Chakraborty’s future research includes the possibility 
of matching highly heritable traits in genetic markers 
against eyewitness testimony. In such a situation, 
DNA markers can determine highly heritable traits 
that can then be compared to eyewitness accounts 
and composite drawings. With new tools and a 
more robust database of offenders, Chakraborty 
hopes to prevent false accusations and remove 
violent criminals from the street as soon as possible.
“The center’s bread and butter is statistical 
modeling,” Chakraborty concludes. “But I want to 
see it applied in a practical and useful way.”
New genomics research
enhances many areas
Joydeep Mallik, Blake Myers and Meredith Turnbough, PhD
Right: Ranajit Chakraborty, PhD
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Rita Patterson, PhD, Nicoleta Bugnariu, PT, PhD,  
and Janice Knebl, DO
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Physical therapy has been used for decades as 
a crucial component in the rehabilitation process of 
individuals who have suffered disorders and injuries 
of the musculoskeletal and/or nervous systems. 
It can help infants with birth defects to aid motor 
development and functional abilities; survivors 
of strokes to regain movement, function and 
independent living; patients with cancer to regain 
strength and relieve discomfort; patients with low 
back problems to reduce pain and restore function; 
and patients with diminished cardiac capacity to 
improve endurance and achieve independence. 
UNT Health Science Center’s Physical Therapy 
Department is taking a creative approach to 
address balance and movement impairments and 
help patients regain functional independence.
Nicoleta Bugnariu, PT, PhD, associate professor 
of Physical Therapy, will conduct clinical research 
using virtual reality equipment called the V-Gait 
Computer Assisted Rehabilitation Environments 
(CAREN) system. This system combines an 
instrumented self-paced, dual-belt treadmill with 
real-time motion capture and a three-dimensional 
interactive virtual environment. 
“The dual belt treadmill is extremely beneficial for 
training balance and walking in stroke or amputee 
patients, as one side of their body may be weaker,” 
Bugnariu said. “The patient is able to move at his 
or her own pace with each leg and the system can 
record their motion and force patterns so we are 
able to see any abnormalities or improvements over 
time. The treadmill is installed on a motion platform 
and its movement corresponds to the surface of the 
virtual environment. For example it can dip, slide or 
be rough just like a walking path going down or up a 
hill, or on an uneven terrain.”
A motion analysis system with 12 cameras tracks 
and records all movements made by patients as 
they interact with the virtual environment. 
The virtual environment can be delivered by two 
means: a 180-degree cylindrical screen or a head-
mounted display. Virtual environments are tailored 
to each patient’s needs, depending on the issues he 
or she needs to address. Patients receive advanced 
physical therapy while experiencing real-life 
activities such as opening a door, crossing a street, 
walking through a forest or driving a boat.
The parameters of the virtual application can be 
set so that small movements will open a door or 
push an object, although it might take a much larger 
movement in a real-life setting. As a patient’s mobility 
improves, these parameters can be adjusted and 
tailored to help them gain the strength needed to 
be able to push, pull and walk outside of the virtual 
setting.
Markers stuck on the patient help track movements on the CAREN virtual reality system.
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“This system provides a safe, controlled 
environment that empowers patients,” Bugnariu 
said. “The movement of this system helps patients 
succeed in everyday activities, which is crucial to 
improving their balance.” 
The V-Gait CAREN will also help researchers 
determine how disease, age, neurological problems 
and brain injuries can affect sensory integration, as 
well as how the brain processes multiple sensory 
modality inputs into usable functional outputs. 
Bugnariu is specifically interested in the mechanisms 
of sensory-motor integration and their impact on 
balance. In collaboration with Janice Knebl, DO, 
chair of Geriatrics and professor of Internal Medicine, 
and Rita Patterson, PhD, professor of Manipulative 
Medicine, Bugnariu hopes that the results from 
this research will lead to better interventions for fall 
prevention in older adults.
“Patients who are mainly dependent on their 
visual sense to keep their balance usually look 
down while they walk,” Bugnariu said. “When they 
have to look up, attend to other visual stimuli or 
perform a second task, they lose their balance and 
fall. But if we are able to train the mechanisms of 
sensory integrations and expand patients’ use of other 
sensory inputs, balance control will be improved.”
The Health Science Center is now one of only 
five locations, and the only academic institution, to 
house a system like this. The other four belong to the 
Department of Defense and primarily focus therapy 
on lower extremities. Bugnariu and Patterson will 
use the Health Science Center’s system to help 
patients train both upper and lower extremities 
simultaneously during functional tasks.
Bugnariu is also collaborating with Advanced 
Arm Dynamics, and the Osteopathic Manipulative 
Medicine and Orthopaedic Surgery departments 
to explore the best ways to train upper-extremity 
amputees. These patients are often younger, will 
live longer and require use of their upper extremities 
throughout their lives.
“With this research we can definitely fill two 
gaps,” Bugnariu said. “First, understanding the 
mechanisms of sensory-motor integration will lead to 
innovations in rehabilitation therapies for balance 
and mobility. Second, the use of virtual environments 
will allow for customized rehabilitation protocols 
that are not only fun and motivating for the patients, 
but are safer and more efficient in promoting 
recovery of function.”
Nicoleta Bugnariu evaluates movements using computer programs.
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Since 2005 the Texas Alzheimer’s Research 
Consortium (TARC) has been researching ways to 
improve prevention, early detection and treatment of 
the most common form of dementia. 
TARC consists of five of the state’s leading medical 
research institutions: the UNT Health Science Center, 
Baylor College of Medicine, the University of Texas 
Southwestern Medical Center, Texas Tech Health 
Science Center and the University of Texas Health 
Science Center San Antonio.
TARC has developed the first blood test for 
Alzheimer’s disease. The test is based upon levels of 
152 proteins in the blood serum. Work began on the 
test in 2005 and continues with patient enrollment 
and follow-up. If validated by TARC researchers 
in an independent group of patients and approved 
by the Food and Drug Administration, this cost- 
effective test will give physicians the ability to routinely 
screen many individuals. Patients who test positive 
for Alzheimer’s disease on the blood test could be 
referred for more advanced neuro-imaging analysis.
This blood test has the potential to revolutionize 
diagnosing and treating Alzheimer’s disease. 
“Including those in the earliest stages of the 
disease is critical because Alzheimer’s disease 
progresses in the brain for quite a while before 
symptoms become apparent,” according to Robert 
Barber, PhD, associate professor of Pharmacology and 
Neuroscience at the Health Science Center and the 
TARC scientific coordinator. 
All drugs and therapies that have been tested in 
clinical drug trials thus far have failed to prevent 
the disease or slow its progress. This could be 
because by the time individuals show clinical signs 
and symptoms, many cells in the brain have died, 
lessening the chance of any treatment successfully 
restoring cognitive function. Effective treatment may 
need to begin well before symptoms of the disease 
become apparent.
For this reason, all TARC sites, including the Health 
Science Center’s Patient Care Center, have begun 
studying patients with mild cognitive impairment. 
These individuals do not have dementia but have 
cognitive impairment beyond what is considered 
normal for their age.
“Using the blood test as a first step in a multi-stage 
screening process could expand care dramatically. 
Currently, a diagnosis can only be made in a specialty 
clinic, usually in large, urban medical centers within 
developed countries. While advanced neuro- 
imaging and cerebrospinal fluid screenings are 
accurate, they are not widely available,” Barber said. 
“The blood test could be administered annually to 
all individuals over 65 who are at an increased risk 
of Alzheimer’s and could be performed nearly 
anywhere, resulting in increased access to care.”
TARC is also working to expand its research 
studies to include patients in the earliest stages of 
the disease and the Hispanic population. The Health 
Science Center is enrolling patients and collecting 
biological samples and neuropsychological data.
TARC sites have enrolled more than 200 
Hispanic patients in studies and plan to enroll more 
than 500 by September 2011. With Hispanics making 
up over one-third of the Texas population and Texas 
expected to become a majority Hispanic state 
between 2025 and 2035, expanded studies in this 
underrepresented group are needed. TARC will study 
cognitively normal individuals, Alzheimer’s patients 
and early-stage Alzheimer’s patients of Hispanic 
origin.
“We know that the Hispanic population has an 
increased incidence of Alzheimer’s disease risk 
factors, such as diabetes, heart disease and 
hypertension,” Barber said. “These factors, and the 
realization that the number of Hispanic Texans is 
increasing dramatically, make it imperative to study 
this underrepresented and at-risk group of Texans.” 
Barber said TARC’s ultimate goal is to end this 
disease by developing and improving methods of 
treatment and prevention.
“This work is important to me because of the 
devastating effect Alzheimer’s disease has on 
patients and their families,” Barber said. “I have a 
strong interest in complex human diseases and AD 
has been the most resistant to the development of an 
effective treatment. Given the aging ‘baby-boomer’ 
generation, this single disease has the potential to 
bankrupt the health care system if effective preventive 
measures or therapies are not developed.”
TARC research continues  
to reveal findings, bring hope 
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As people age, the threat of a debilitating stroke increases. Rebecca 
Cunningham, PhD, research assistant professor in the Department of 
Pharmacology and Neuroscience at the UNT Health Science Center, 
is on a quest to determine if testosterone — especially in older men— 
contribute to the damage caused by ischemic stroke. 
The research is looking into the biological effects of testosterone, 
the male hormone, on neurons in the brain and the reasons why males 
suffer worse effects from stroke. When these effects are better under-
stood, Cunningham hopes to identify a novel therapy to lower the risk of 
ischemic stroke in men. 
A stroke increases the likelihood of a condition termed oxidative 
stress, which has been shown to damage brain tissue. Androgens such 
as testosterone can further increase oxidative stress. Together they 
create a perfect storm that increases cell vulnerability.
“Testosterone decreases cell survivability by increasing calcium that 
harms the cell by overstimulation,” Cunningham said. As part of her 
research, Cunningham creates oxidative stress on a cell similar to that 
caused by stroke and age. It also creates lost connections that can 
result in movement disorders similar to Parkinson’s disease.
“We believe that testosterone only exhibits ‘negative’ effects on 
dopamine neurons in an impaired cellular environment, such as during 
aging and stroke,” Cunningham concluded. “We hope to find a way to 
maintain the positive effects of testosterone while mitigating the 
negative effects.“
Does testosterone 
create more stroke 
damage in males?
22     unthsc.edu/research
Rebecca Cunningham, PhD
Synergy 2011     23
If you lived in a controlled environment, eating only 
nutritious meals and working out regularly with a 
trainer, would you reduce your risk for cardiovascular 
disease and diabetes — even if you are genetically 
predisposed for these diseases?
Mark DeHaven, PhD and founder of a ground-
breaking study, says research shows that those who 
live in an environment where nutrition and exercise 
are carefully monitored can indeed reduce their risk 
for these diseases, even if their genes are working 
against them. It’s a result of the epigenome — the 
chemical compounds, separate from the underly-
ing DNA sequence, that tell the gene what to do. 
Scientists are discovering that epigenetic mecha-
nisms allow organisms — human and otherwise — to 
respond to the environment and actually regulate 
gene expression.
But people live in an ever-changing world with 
all its stressors. DeHaven, UNTHSC’s Health Insti-
tutes of Texas professor and director of the Texas 
Prevention Institute, is conducting the coun-
try’s first large-scale faith- and community-based 
participatory research trial to determine whether 
people can reduce risk factors for chronic diseases 
while living in the real world. The study is funded by 
the National Institutes of Health’s Heart, Lung and 
Blood Institute.
The program, called GoodNEWS (Genes, Nutri-
tion, Exercise, Wellness and Spiritual Growth) shows 
great promise for reducing cardiovascular disease 
and diabetes risks.
“Our team has always been seeking ways to 
reduce risks for these diseases that can be 
implemented in a community setting, and that are 
effective,” said DeHaven, who is working with black 
church congregants in South Dallas to determine if 
community-based efforts to encourage healthy diets 
and exercise reduce risk factors for heart disease, 
stroke and diabetes.
Care-related factors are commonly reported to 
account for only 10 percent of a person’s risk of pre-
mature mortality, whereas 
lifestyle and behaviors 
represent 50 percent. 
Twenty percent is related 
to environment, and 
another 20 percent is 
genetics.
“This tells us that 
we do have a great 
deal of control over our 
health,” DeHaven said. 
“Our study participants had always assumed they 
would die young because their relatives died young. 
Now they get it — they know that they can influence 
their risk factors for these diseases. They know they 
don’t have to die young.” 
One barrier South Dallas residents face to a healthy 
lifestyle is a lack of stores selling fresh fruits and 
vegetables. There is one grocery story for every 
35,000 South Dallas residents, DeHaven said, and 
most end up buying groceries at convenience 
stores that carry little produce. 
After limited success in encouraging grocery 
stores to open in the area, DeHaven launched the 
Healthy Harvest Community Gardening effort.
Seven gardens have been developed, and three 
more are in planning — thanks in part to donations 
from Dallas developer and philanthropist Trammell 
S. Crow. Along with the UNT Health Science Center, 
other contributors and participants include PepsiCo, 
St. Philips Academy and Community Center, Paul 
Quinn College and several southern Dallas County 
congregations. 
In most cases, the gardens begin when a church 
buys a condemned lot and removes the dwelling. 
Then the land is used to grow food, revitalize 
neighborhoods and provide a safe location for 
physical activity.
DeHaven is seeking funding for a similar program 
in Fort Worth. 
Can healthy habits 
counter genetics?
GoodNEWS and Healthy Harvest
Mark DeHaven, PhD
Encore Vision gives insight into presbyopia 
Encore Vision, a TECH Fort Worth company leasing 
laboratory space from the UNT Health Science 
Center, is developing an eye-drop treatment for 
presbyopia that may offer an alternative to reading 
glasses. Presbyopia, the inability to focus on nearby 
objects, has an age of onset around 40 to 45, and 
remains throughout life. Presbyopia makes it difficult 
to read a newspaper, do needlework or perform tasks 
requiring close-up work.
William Burns, CEO of Encore Vision, notes that 
as people age, they lose the ability to focus on 
objects less than an arm’s length away. The new eye 
drop being developed delivers a drug that softens 
the lens, allowing the lens to better focus on nearby 
objects.
“We are supplying a derivative of an agent that is 
always present in cells of the eye,” Burns said. “The 
drops will put more of that agent back in, allowing 
the chemical reduction of aberrant chemical bonds. 
This will soften the lens, restoring flexibility again and 
decreasing the viscosity of lens cells.”
Encore Vision has completed the first phase of 
research and identified safe compounds that are 
derivatives of natural products of the eye. In the 
next development phase, toxicology studies will be 
conducted to identify safe dosing levels. Burns said 
they want to make sure that the product is comfort-
able, shelf-stable and sterile, and then clinical trials 
will begin. A portion of those studies will be conducted 
at the Health Science Center.
“We should know within the next two years how this 
is going to work in humans, the dosing frequency and 
duration of treatment required, and the safety evalu-
ation through clinical trials and beyond,” Burns said.
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ZS Pharma receives $2M from 
Emerging Technology Fund investment
Another TECH Fort Worth Client leasing office 
space from the UNT Health Science Center, ZS 
Pharma, Inc., has received $2 million in an 
Emerging Technology Fund (ETF) investment 
from the State of Texas. This investment will 
provide ZS Pharma the funds to develop oral 
sorbents designed to reduce abnormally high levels 
of agents that build up in patients with either liver 
or kidney disease. At the Health Science Center, ZS 
Pharma will spend a portion of the ETF funding on 
activities to advance the commercialization of its 
technology. 
ZS Pharma’s core technology platform uses 
zirconium silicate crystals to specifically target ions 
and molecules, such as potassium, ammonium, 
urea and phosphate, that have built up in the body 
as a result of liver or kidney failure. There is currently 
no effective treatment for hyperkalemia, or high 
levels of potassium in the blood, and treatments 
that do exist are not suited for chronic conditions 
that require constant treatment. Taken with food, 
ZS Pharma’s tasteless and odorless therapy should 
provide an alternative to hemodialysis, which 
is costly, demanding of the patient and potentially 
dangerous. The new advanced compound could 
be a significant medical breakthrough for treatment 
of acute and chronic hyperkalemia, providing a 
better quality of life and an alternative to dialysis and 
other expensive medical procedures.
The ETF investment fund was designed to attract 
Texas’ top scientists and entrepreneurs in growing 
areas including life science technologies and 
pharmaceutical development. 
William Burns, Encore Vision
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A recent Gallup poll indicates that Americans 
are drinking more than they have in the last 25 
years. As a result, alcoholism continues to be 
a problem among adults and adolescents, and 
withdrawal from alcohol continues to disrupt 
lives as individuals and their families deal with 
both the physical and emotional trauma of 
weaning their bodies and minds from the effects 
of alcohol abuse. New research at the Health 
Science Center examines the effects of 
intermittent hypoxia — cycles of a moderately 
low level versus a normal level of oxygen — on 
the body’s ability to adjust to alcohol withdrawal. 
“When a patient is exposed to intermittent 
hypoxia over time, the body learns to adapt to 
the stress of low oxygen,” said Marianna Jung, 
PhD (’97), assistant professor of Pharmacology 
and Neuroscience and principal investigator for 
the study, funded by the National Institutes of 
Health. “By introducing intermittent hypoxia for 
20 days and training the brain to deal with stress, 
we hope to show that the brain can be protected 
from excessive stress of alcohol withdrawal.”
At the suggestion of Fred Downey, PhD, 
professor and vice chair of Integrative Physiology, 
Jung is working with Robert Mallet, PhD, professor 
of Integrative Physiology, in testing the theory. 
During the first phase of testing, animal subjects 
exposed to intermittent hypoxia prior to experiencing 
sudden alcohol withdrawal were calmer 
and suffered less stress than subjects who 
were not subjected to hypoxia pre-conditioning. 
Subjects without hypoxia treatment were more 
hyperactive and more apt to suffer seizures during 
withdrawal. The second phase of testing showed 
a continued protective factor relative to the overt 
signs of alcohol withdrawal including tremors, 
rigidity and irritability. At this point, it’s not clear if 
the residual effect of the hypoxia is true for all 
 ethanol withdrawal-induced effects.
The hope is that further evaluation will result in 
therapies that can improve the recovery time for 
patients experiencing alcohol withdrawal.
Hypoxia may reduce
sudden alcohol withdrawal distress
Marianna Jung, PhD
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Setting the standard
Before a new drug can be marketed and dispensed 
by a physician, it faces a long, circuitous route from 
the laboratory through rigorous testing and protocols. 
Commercial pharmaceutical companies need reliable, 
efficient testing of new and novel compounds at the 
bench level, in animal models and on into pre-clinical 
testing. That’s where the UNT Health Science Center’s 
Pre-Clinical Services has stepped up.
Part of the Department of Molecular Biology and 
Immunology, the group evaluates the efficacy and 
safety of pharmaceutical products before they 
become available to the public, merging academics 
and industry in the quest to discover and develop 
new drugs.
“We provide the expertise to help take a drug from 
laboratory to bedside,” said Jerry Simecka, PhD, 
executive director of Pre-Clinical Services. “We 
work with companies and academic researchers to 
discover treatments for everything from skin infections 
to pneumonia. Some companies are hesitant to work 
with universities due to issues of intellectual property, 
but we have been able to address those concerns. 
As a result, we are building a world-wide reputation 
for solid work.”
In state-of-the-art facilities, Pre-Clinical Services 
staff members guide the drug discovery process 
through protocol design, implementation and 
analysis. Together the staff — which has doubled 
in size to 12 in the past two years — has more than three 
decades of large pharmaceutical and specialized 
biotech experience in therapeutic efficacy models 
and drug discovery and development. Simecka 
expects to expand the operation and handle more 
than 50 projects per year.
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and Mark Pulse, PhD
“Some of these evaluations can be completed in 
one or two days,” Simecka explained, “while others 
can take much more time. But through the process 
we’ve learned how to conduct the evaluations more 
efficiently and quickly.”
Pre-Clinical Services has executed more than 
100 contracts with biotech firms and pharmaceu-
tical companies in the U.S. and Europe, as well as 
other universities across the country. Some studies 
are funded by grants, but many are commissioned 
by commercial organizations. Among the capabilities 
of the group is the ability to evaluate antibacte-
rial agents and establish models of both acute and 
chronic bacterial infections.
Various additional studies and analyses can be per-
formed in house. Infection models or other protocols 
can be established and adapted to meet more specif-
ic client needs. In collaboration with the Department 
of Laboratory Animal Medicine, Good Laboratory 
Practice (GLP) procedures were recently established. 
The GLP standards are in place to ensure the 
consistency, reliability and documentation required 
for submission of regulatory documents to the Food 
and Drug Administration prior to clinical trials.
“In the drug industry, there’s been a huge shift. 
Companies have downsized and gotten away from 
the ability to perform pre-clinical studies,” said 
William Weiss, director of Pre-Clinical Services. 
“That’s why they need organizations like ours. They 
are looking for experienced people who know how 
to perform the pre-clinical work. We bring industry 
experience and provide the rationales.”
Research funding by the numbers
Research at the Health Science Center continues to grow, reaching 
an all-time high of nearly $40 million in 2010. Since 2000, our research 
expenditures have increased by nearly 300 percent.  
Our scientists receive support for their research from a variety of 
funding sources.  In 2010, over 70 percent of the research awards 
to UNT Health Science Center investigators were from the federal 
government. The majority of federal support was from the National 
Institutes of Health (NIH), considered the gold standard when judging 
quality of biomedical research. Whereas the federal stimulus bill 
infused drastically needed funding into the NIH research budget for 
2009 and 2010, overall funding has been relatively flat on average 
for the past several years. Our growth in research funding from NIH 
dramatically exceeds the overall national average. This is strong 
evidence of the exceptional, high-quality research being conducted 
by our faculty at the Health Science Center.
We are committed to creating solutions for a healthy community 
through research. Our investigators will continue to perform cutting- 
edge research in critical areas including aging and Alzheimer’s 
disease, investigative genetics, cardiovascular disease, vision, cancer 
and disease prevention. Our emphasis on expanding translational 
research will help to increase the pace of discovery, and its conversion 
to new therapeutics and treatments.
UNT Health Science Center. Our discoveries. Your Health.
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NIH funding growth
far exceeds national average
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Health Institutes of Texas
Cardiovascular Research Institute (CRI)
The	 CRI	 seeks	 to	 further	 our	 understanding	 of	 cardiovascular	
disease	 and	 improve	 the	 techniques	 used	 in	 the	 prevention,	
detection,	 diagnosis	 and	 treatment	 of	 cardiovascular	 disease	
and	 the	 rehabilitation	 of	 its	 victims	 by	 targeting	 myocardial	
infarction,	hypertension,	congestive	heart	failure	and	stroke.
Center for Commercialization  
of Fluorescence Technologies (CCFT)
Funded	by	an	Emerging	Technology	Fund	grant	from	the	governor	
of	Texas,	 the	 CCFT	 works	 to	 develop	 and	 commercialize	 new	
approaches	 for	diagnostics	and	 treatment	using	 the	emerging	
fields	of	nanophotonics	and	nanotechnology.	
Center for Women’s Health (Focused on Resources  




Institute for Aging and Alzheimer’s Disease  
Research (IAADR)
The	 IAADR	 focuses	 on	 early	 detection	 of	Alzheimer’s	 disease,	
estrogen’s	role	in	Alzheimer’s	and	Parkinson’s	diseases,	stroke	
therapy	 and	 identification	 of	 oxidation	 processes	 to	 measure	
brain	aging,	with	several	treatment	drugs	in	clinical	trials.
Institute for Cancer Research (ICR)
The	 ICR	provides	 leadership	 in	all	aspects	of	cancer	research,	
education	and	training.	
Institute for Investigative Genetics (IIG)
The	 mission	 of	 IIG	 is	 to	 improve	 safety,	 security	 and	 quality	
of	 life	through	the	application	of	genetics.	The	mission	is	met	
through	 the	 institute’s	 three	 centers:	 the	 Center	 for	 Human	
Identification,	 the	Center	 for	Computational	Genetics,	 and	 the	
Center	for	Biosafety	and	Biosecurity.
Mental Science Institute (MSI)
The	 mission	 of	 MSI	 is	 to	 foster	 a	 greater	 understanding	 of	
human	thought	and	behavior	through	interdisciplinary	research	
and	 education.	 The	 MSI	 conducts	 multidisciplinary	 research,	
and	provides	education	and	consultation	in	the	mental	sciences	
associated	with	human	behavior.
North Texas Eye Research Institute (NTERI)
NTERI	is	dedicated	to	preserving	vision	and	curing	eye	disease	
by	using	basic	research,	clinical	research	and	medical	education	
of	clinicians	and	scientists	 to	 improve	 treatment	of	glaucoma,	
age-related	 macular	 degeneration,	 diabetic	 retinopathy	 and	
other	vision	disorders.
Osteopathic Research Center (ORC) 
The	ORC,	housed	at	the	Health	Science	Center	campus,	 is	the	
national	 center	 of	 collaborative	 research	 on	 the	 efficacy	 of	
osteopathic	manipulative	medicine	through	multi-center	clinical	
trials,	 teaching	 research	 skills	 and	 promoting	 collaborative	
studies.
Texas Prevention Institute (TPI)
The	 Texas	 Prevention	 Institute	 is	 dedicated	 to	 conducting	
innovative	translational	research	focusing	on	primary	care	and	
chronic	 disease	 prevention.	 It	 is	 composed	 of	 the	 Center	 for	
Community	Health,	the	Primary	Care	Research	Institute	and	the	
Texas	Center	for	Health	Disparities.		
The Health Institutes of Texas were designed to leverage the Health Science 
Center’s growing expertise in public health, interdisciplinary scientific research, 
medical education and healthcare delivery. The ultimate goal is to use this 
model among various institutes to improve the health of Texans and beyond by 
reducing disparities, developing new treatments and therapies, and improving 
access to care in rural and underserved communities in Texas.
Walking the talk was a buzz phrase several years ago 
when leaders often paid lip service to a phrase or direction 
but didn’t actually live by their words. But at the UNT 
Health Science Center, our researchers really epitomize 
the word “collaboration.” Walking around our campus, I’m 
often struck by the collegial atmosphere here. 
From graduate students studying the effects of pyruvate 
to clinical faculty working together with world-renowned 
researchers to physicians treating patients with new 
protocols, the UNT Health Science Center prides itself 
on the collaborative, multi-dimensional work environment 
and broad research relationships on campus. Our recent 
addition of virtual reality simulation therapy is the 
perfect opportunity to use our expertise in motion-related 
rehabilitation with the brand new physical therapy program 
to treat elderly patients under the care of a Reynolds grant 
expert.
The interrelationships here at the Health Science Center 
enrich our research and help us bring a broader 
understanding to a variety of research areas. Our intimate, 
tightly woven community and close proximity on campus 
lend themselves to information sharing, as well as testing 
and evaluation.
The addition of the Center for Computational Genomics 
creates an exciting group that will help analyze bioinfor-
matics on everything from low-back pain in patients at the 
Osteopathic Research Center to biomarkers for prostate 
cancer and familial DNA samples in prosecuting criminals. 
By bringing the brightest minds at all levels together, we create a unique opportunity 
to learn from one another, share new insights, present new questions and analyze 
a variety of different approaches and perspectives in our daily research.
It’s not unusual to see a professor hail a physician or graduate student as each 
makes his or her way across campus, then proceed to confer about the latest 
new idea that could have far-reaching effects. These researchers, grad students 
and faculty are walking and talking and dreaming and doing. And the steps we 
are taking may lead to discoveries that will improve the journey for humankind.
There’s a collegial energy and excitement on our campus that’s contagious. And 
that’s one virus that I hope continues to spread. Come experience it for yourself!








The poster and oral competition 
among students, postdoctoral 
fellows and residents is an 
institutional tradition encomp-
assing medicine, public health 
and basic science. Students, 
faculty and staff share their 
research efforts with the campus 
community and the public, in 
addition to competing before an 
expert panel of judges. 
Learn about new research discoveries at the
19th Annual Research Appreciation Day
Our Discoveries. Your Health. 
www.unthsc/RAD
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